Amphion Innovations (AMP)

 

AMP Share PerformanceMore

52 week high4.7000 21/04/17
52 week low0.8150 28/11/17
52 week change -0.8750 (-38.89%)
4 week volume28,780,934 18/11/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Issue of Shares

RNS Number: 3582Y Amphion Innovations PLC 05 December 2017 AMPHION INNOVATIONS PLC ("Amphion" or "the Company") Share Issuance London and New York, Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces that the Company has issued 1,664,659 ordinary shares, representing 0.80...

These five AIM firms could own the tech stars of tomorrow

Former AIM writer of the year Andrew Hore has found a handful of great companies with exposure to technology that c...

Amphion update on Polarean's proposed IPO

Amphion Innovations has issued a further update on its 26%-held Polarean Imaging. Amphion said that Polarean's propose...

Further Update on Polarean Imaging Limited

RNS Number: 2832X Amphion Innovations PLC 23 November 2017 Amphion Innovations plc ("Amphion" or "the Company") Further Update on Polarean Imaging Limited London and New York, 23 November 2017 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces a further update regarding its pa...

Amphion update on Polarean Imaging

Amphion Innovations has issued an update regarding its partner company Polarean Imaging Limited, in which Amphion ...

Update on Polarean Imaging Limited

RNS Number: 1121W Amphion Innovations PLC 10 November 2017 Amphion Innovations plc ("Amphion" or "the Company") Update on Polarean Imaging Limited London and New York, 10 November 2017 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, is pleased to announce an update regarding its partner...

DataTern case against MicroStrategy dismissed

Amphion Innovations said a case brought by its wholly-owned subsidiary DataTern against MicroStrategy Inc and certain...

Order Dismissing DataTern Case

RNS Number: 3333V Amphion Innovations PLC 02 November 2017 Amphion Innovations plc ("Amphion" or "the Company") Order Dismissing DataTern Case London and New York, 2 November 2017 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that on 20 October 2017 the case brought by D...

Latest discussion posts More

  • Re: Expensive drawdown facility

    What to do? Sell or avoid? Have been watching this, but any upside to Motif will simply mean AMP selling stake to pay the debt/bills? Will any Motif windfall be squandered? ...
    15-Jul-2016
    bobsson
  • Re: Expensive drawdown facility

    Agree wholeheartedly! Conflicted company officers are electing, against their fiduciary duty, to unecessarily bleed our company dry when cheaper funding could clearly be ...
    13-Jul-2016
    nodebt
  • Expensive drawdown facility

    This facility seems very expensive $750,000 borrowed today and $881,000 having to be repaid in less than 4 months time and some of it being used to pay back a previous ...
    13-Jul-2016
    northumbrian-piper

Users' HoldingsMore

Users who hold Amphion Innovations also hold..

Codes & Symbols

ISINGB00B0DJNP99
SymbolsAMP, LSE:AMP, AMP.L, AMP:LN, LON:AMP, XLON:AMP

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account